DDM-PGE2-mediated cytoprotection in renal epithelial cells by a thromboxane A2 receptor coupled to NF-κB

American Journal of Physiology - Renal Physiology

Volumn 278, Issue 2 47-2, 2000, Pages

  Weber, Thomas J ^a,b   Monks, Térrence J ^a   Lau, Serrine S ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

Kidney; Protein kinase C; Quinone thioether; TP receptor

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 16,16 DIMETHYLPROSTAGLANDIN E2; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 7 [3 [3 HYDROXY 4 (4 IODOPHENOXY) 1 BUTENYL] 7 OXABICYCLO[2.2.1]HEPTAN 2 YL] 5 HEPTENOIC ACID; ACETYLSALICYLIC ACID; HYDROQUINONE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN SYNTHASE INHIBITOR; SALAZOSULFAPYRIDINE; THROMBOXANE A2 RECEPTOR; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; THROMBOXANE SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL STRAIN; CONTROLLED STUDY; DNA BINDING; DNA TRANSCRIPTION; DRUG CYTOTOXICITY; KIDNEY EPITHELIUM; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0034012453     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.278.2.f270     Document Type: Article

References (39)

1. Abe, T., K. Takeuchi, N. Takahashi, E. Tsutsumi, Y. Taniyama, and K. Abe. Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization. Cancer Res. 96: 657-664, 1995.
2. Armstrong, R. A., and N. H. Wilson. Aspects of the thromboxane receptor system. Gen. Pharmacol. 26: 463-472, 1995.
3. 2 receptor. Production, purification and characterization. Biochem. Pharmacol. 45: 2071-2078, 1993.
4. 2 receptors by immunoaffinity chromatography employing anti-peptide and anti-receptor antibodies. J. Biol. Chem. 269: 6109-6116, 1994.
5. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
6. Bruggeman, L. A., E. A. Horigan, S. Horikoshi, P. E. Ray, and P. E. Klotman. Thromboxane stimulates synthesis of extracellular matrix proteins in vitro. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 261: F488-F494, 1991.
7. 2 receptor: high affinity for the agonist ligand I-BOP. Prostaglandins 52: 303-316, 1996.
8. 2-isoprostane. Biochem. Biophys. Res. Commun. 195: 507-515, 1993.
9. 2. Am. J. Physiol. Renal Physiol. 272: F477-F483, 1997.
10. Guth, P. H., G. Paulsen, and K. Hirabayashi. Prostaglandin cytoprotection. Prostaglandin does not protect against aspirin- or alcohol-induced red blood cell hemolysis. Dig. Dis. Sci. 28: 903-907, 1983.
11. Guth, P. H., G. Paulsen, H. Nagata, F. Leung, A. Robert, and Y. Ohya. Prostaglandin cytoprotection: role of microcirculatory changes. Adv. Prostaglandin Thromboxane Leukot. Res. 15: 637-639, 1985.
12. Habib, A., G. A. Fitzgerald, and J. MacLouf. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. J. Biol. Chem. 274: 2645-2651, 1999.
13. 2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J. Clin. Invest. 97: 949-956, 1996.
14. 12. Prostaglandins Other Lipid Mediators 55: 159-168, 1998.
15. 2 analog (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells. Biochem. J. 326: 593-599, 1997.
16. Karin, M., and T. Smeal. Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem. Sci. 17: 418-422, 1992.
17. Ko, F. N., S. M. Yu, Y. F. Kang, and C. M. Teng. Characterization of the thromboxane (TP) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat. Br. J. Pharmacol. 116: 1801-1808, 1995.
18. Krauss, A. H., D. F. Woodward, L. L. Gibson, C. E. Protzman, L. S. Williams, R. M. Burk, T. S. Gac, M. B. Roof, F. Abbas, K. Marshall, and J. Senior. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha. Br. J. Pharmacol. 117: 1171-1180, 1996.
19. La Porta, C. A., and R. Comolli. PKC-dependent modulation of IkB alpha-NFκB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells. Anticancer Res. 18: 2591-2597, 1998.
20. Lau, S. S., B. A. Hill, R. J. Highet, and T. J. Monks. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. Mol. Pharmacol. 34: 829-836, 1988.
21. Li, J. J., C. Westergaard, P. Ghosh, and N. H. Colburn. Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res. 57: 3569-3576, 1997.
22. 2, on the platelet thromboxane/ endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. Prostaglandins 48: 247-256, 1994.
23. 2 receptor (TP) alpha and beta isoforms. Biochim. Biophys. Acta 1425: 543-559, 1998.
24. 2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets. J. Biol. Chem. 265: 21670-21675, 1990.
25. 2 stimulates mitogen-activated protein kinase and arachidonic acid liberation in rabbit platelets. Prostaglandins 52: 403-413, 1996.
26. Olson, E. N., R. Burgess, and J. Staudinger. Protein kinase C as a transducer of nuclear signals. Cell Growth Differ. 4: 699-705, 1993.
27. Remuzzi, G., G. A. Fitzgerald, and C. Patrono. Thromboxane synthesis and action within the kidney. Kidney Int. 41: 1483-1493, 1992.
28. Robert, A. Cytoprotection by prostaglandins. Gastroenterology 77: 761-767, 1979.
29. Ruwart, M. J. Protection of the liver against various damaging agents. In: Biological Protection With Prostaglandins, edited by M. M. Cohen. Boca Raton, FL: CRC, 1986, p. 229-243.
30. 2 and vascular smooth muscle cell proliferation. Hypertension 26: 771-780, 1995.
31. 2 receptor or protein kinase C. Biochem. J. 321: 525-530, 1997.
32. Siebenlist, U., G. Franzoso, and K. Brown. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405-455, 1994.
33. Spurney, R. F. Role of C-terminal serines in desensitization and phosphorylation of the mouse thromboxane receptor. J. Biol. Chem. 273: 28496-28503, 1998.
34. Stenson, W. F., and E. Lobos. Inhibition of platelet thromboxane synthetase by sulfasalazine. Biochem. Pharmacol. 32: 2205-2209, 1983.
35. 2 receptors. J. Clin. Invest. 90: 136-141, 1992.
36. 2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems. J. Biol. Chem. 265: 6836-6844, 1990.
37. Wahl, C., S. Liptay, G. Adler, and R. M. Schmid. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest. 101: 1163-1174, 1998.
38. 2-mediated cytoprotection in renal epithelial cells: evidence for a pharmacologically distinct receptor. Am. J. Physiol. Renal Physiol. 273: F507-F515, 1997.
39. 2 receptor subtypes. Circ. Res. 80: 551-556, 1997.